FDA Enhances Salt Iodisation Oversight at Ada Songor to Combat Iodine Deficiency

The Food and Drugs Authority (FDA) has intensified its efforts to ensure that all salt intended for human consumption in Ghana is adequately iodised and meets stringent safety standards. Speaking at the launch of a new salt fortification program at Ada Songor, Mr. Benjamin Osei Tutu, representing the FDA, reaffirmed the authority's commitment to eliminating iodine deficiency disorders (IDD). This initiative aims to bolster the monitoring of salt production sites and markets to ensure that the salt reaching Ghanaian households contains the necessary iodine levels mandated by law.

A critical component of this renewed drive is the prevention of cross-contamination between industrial salt and edible salt. Mr. Osei Tutu issued a stern warning to producers against the practice of mixing these two types of salt, which can pose significant health risks to consumers. To support local production, the Ada Songor Lagoon Association (ASLA) has taken proactive steps by securing a steady supply of iodine for local artisans. Furthermore, ASLA is conducting specialized training sessions for these artisans to ensure they adhere to proper dosage requirements and iodisation practices, thereby maintaining the quality and safety of the final product.

Beyond health and safety, the program also seeks to address economic concerns within the salt industry. By regulating the market and ensuring a consistent supply of fortified salt, the FDA and ASLA aim to stabilize salt prices, protecting both producers and consumers from market volatility. This effort involves a multi-stakeholder approach, bringing together Environmental Health Officers, the Ghana Police Service, and the Judicial Service to enforce compliance. Salt iodisation has been a legal requirement in Ghana since 1994, and these latest measures represent a significant step in fulfilling the country's long-standing public health commitment to eradicating iodine-related health issues.